Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen SAS
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females 18 years of age or greater.
At baseline, moderate to severe dry eye condition persisting despite conventional management.
You may not be if
Presence or history of any systemic or ocular disorder or condition, including ocular surgery, trauma or disease that could possibly interfere with the interpretation of study results.
Any relevant ocular anomaly interfering with the ocular surface, including post radiation keratitis, Stevens-Johnson syndrome, corneal ulcer history or concomitant corneal ulcer of infectious origin, etc.
Any other ocular diseases requiring topical ocular treatment during the study period.
Patient who has participated in a clinical trial with a new active substance during the past month before study entry.
Participation in another clinical study at the same time as the present study.
Clareo Health | Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
